CHICAGO (WBBM Newsradio) - As global public health officials now scramble to contain the highly infectious hantavirus, seen recently transmitted from person to person on a cruise ship, the Wall Street Journal reports that there are already a number of potential vaccine or treatment options awaiting human trial.
One option is an antibody which has shown to protect hamsters from the Andes strain in question, the results first published in 2022, but an international consortium of researchers are still in need of funding to proceed any further. This includes researchers from universities, biotech companies, and a U.S. military research institute.
Moderna has been working on a vaccine for the hantavirus since 2024, in a collaboration with the US Army Medical Research Institute of Infectious Diseases.
